Abstract

A major challenge for the successful treatment of drug addiction is the long-lasting susceptibility to relapse and multiple processes that have been implicated in the compulsion to resume drug intake during abstinence. Recently, the orexin/hypocretin (Orx/Hcrt) system has been shown to play a role in drug-seeking behavior. The Orx/Hcrt system regulates a wide range of physiological processes, including feeding, energy metabolism, and arousal. It has also been shown to be recruited by drugs of abuse. Orx/Hcrt neurons are predominantly located in the lateral hypothalamus that projects to the paraventricular nucleus of the thalamus (PVT), a region that has been identified as a “way-station” that processes information and then modulates the mesolimbic reward and extrahypothalamic stress systems. Although not thought to be part of the “drug addiction circuitry”, recent evidence indicates that the PVT is involved in the modulation of reward function in general and drug-directed behavior in particular. Evidence indicates a role for Orx/Hcrt transmission in the PVT in the modulation of reward function in general and drug-directed behavior in particular. One hypothesis is that following repeated drug exposure, the Orx/Hcrt system acquires a preferential role in mediating the effects of drugs vs. natural rewards. The present review discusses recent findings that suggest maladaptive recruitment of the PVT by drugs of abuse, specifically Orx/Hcrt-PVT neurotransmission.

Highlights

  • Drug addiction is a chronic relapsing disorder characterized by persistent drug-seeking and drug-taking behaviors (O’Brien and McLellan, 1996; Leshner, 1997; O’Brien et al, 1998; McLellan et al, 2000)

  • In agreement with this hypotheses, other studies have shown that microinjection of the Hcrt-r2 antagonist (2S)-1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-di methyl-2-[(4-pyridinylmethyl)amino]-1-butanone hydrochloride (TCSOX229) but not SB334867 into the paraventricular nucleus of the thalamus (PVT) significantly attenuated the expression of naloxone-induced conditioned place aversion (CPA; Li et al, 2011), implying a specific role for PVT Hcrt-r2 in mediating morphine withdrawal

  • Orx-A/Hcrt-1-induced reinstatement in the long-access cocaine (LgA) group produced a left-upward shift of the dose-response function compared with the sweetened condensed www.frontiersin.org milk (SCM) group and an upward shift compared with the short-access cocaine (ShA) group. These findings suggest that a history of cocaine dependence leads to neuroadaptive changes at the level of the PVT, resulting in “sensitization” of LH-PVTOrx/Hcrt transmission, reflected by increased sensitivity and exacerbated behavioral responses to the effects of Orx-A/Hcrt-1, further implicating Orx/Hcrt-PVT transmission in cocaine-seeking behavior and the specific involvement of the PVT in the neurocircuitry associated with cocaine seeking

Read more

Summary

BEHAVIORAL NEUROSCIENCE

The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior. The orexin/hypocretin (Orx/Hcrt) system has been shown to play a role in drug-seeking behavior. Not thought to be part of the “drug addiction circuitry”, recent evidence indicates that the PVT is involved in the modulation of reward function in general and drug-directed behavior in particular. Evidence indicates a role for Orx/Hcrt transmission in the PVT in the modulation of reward function in general and drugdirected behavior in particular. The present review discusses recent findings that suggest maladaptive recruitment of the PVT by drugs of abuse, Orx/Hcrt-PVT neurotransmission

INTRODUCTION
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call